NK-92

Live / Registered — Registered — partial Sections 8 & 15 accepted and acknowledged (as of 16 Aug 2025)

What this means for you

Registered since 10 Jul 2018. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 10 Jul 2028: the §8 & §9 renewal).

Record

Serial number
87701224
Registration number
5512531
Mark type
Word mark
Filed
29 Nov 2017
Published for opposition
24 Apr 2018
Registered
10 Jul 2018
Next maintenance filing
§8 & §9 renewal, due by 10 Jul 2028 (grace period to 10 Jan 2029)
Attorney of record
Alicia M. Passerin

Goods and services

  • Class 001 — Chemicals: Cells for scientific, laboratory, medical, clinical, therapeutic, and diagnostic research; cell-derived preparations, namely, natural killer cell-derived preparations, for scientific, laboratory, medical, clinical, therapeutic, and diagnostic research; Kits comprised of cells, reagents and related instructions, for clinical, medicinal, and therapeutic research purposes; kits comprised of cell-derived preparations, namely, natural killer cell-derived preparations, reagents and related instructions, for clinical, medicinal, and therapeutic research purposes
  • Class 005 — Pharmaceuticals: [ Cells for clinical, medical, veterinary, and therapeutic purposes; cell-derived preparations, namely, natural killer cell-derived preparations, for clinical, medical, veterinary, and therapeutic purposes; therapeutic products derived from cells, namely, natural killer cells, for clinical, medical, veterinary, and therapeutic purposes; therapeutic products derived from cell-derived preparations, namely, natural killer cell-derived preparations, for clinical, medical, veterinary, and therapeutic purposes; Kits comprised of cells, reagents and related instructions, for clinical, medicinal, veterinary, and therapeutic purposes; kits comprised of cell-derived preparations, namely, natural killer cell-derived preparations, reagents and related instructions, for clinical, medicinal, veterinary, and therapeutic purposes ]
  • Class 042 — Scientific and technological services: Research in the field of cancer; product development in the fields of science, medicine, pharmaceuticals, veterinary medicine, therapeutics and research related thereto

Owner

Prosecution history

  • 16 Aug 2025 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
  • 16 Aug 2025 — REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
  • 15 May 2025 — TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
  • 20 Nov 2024 — POST REGISTRATION ACTION MAILED - SEC. 8 & 15
  • 20 Nov 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
  • 06 Jun 2024 — TEAS SECTION 8 & 15 RECEIVED
  • 10 Jul 2023 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
  • 09 Jun 2021 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
  • 10 Jul 2018 — REGISTERED-PRINCIPAL REGISTER
  • 24 Apr 2018 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
  • 24 Apr 2018 — PUBLISHED FOR OPPOSITION
  • 04 Apr 2018 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
  • 20 Mar 2018 — APPROVED FOR PUB - PRINCIPAL REGISTER
  • 13 Mar 2018 — ASSIGNED TO EXAMINER
  • 09 Dec 2017 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

View this trademark record on Rightsy